HRTX - Heron Therapeutics rises on securing label expansion for pain therapy
2024-01-24 06:28:18 ET
Heron Therapeutics ( NASDAQ: HRTX ) shares rose over 7% premarket on Wednesday after the U.S Food and Drug Administration approved label expansion for the biotechnology company's postoperative pain management solution, Zynrelef (bupivacaine and meloxicam)....
Heron Therapeutics rises on securing label expansion for pain therapy